1-3 of 3
Greg Fulcher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

Free
Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Kirk Ways, Mehul Desai, Wayne Shaw, George Capuano, Maria Alba, Joel Jiang, Frank Vercruysse, Gary Meininger, David Matthews, on behalf of the CANVAS Trial Collaborative Group
Journal: Diabetes Care
Diabetes Care 2015;38(3):403–411
https://doi.org/10.2337/dc14-1237
Published: 02 December 2014
View articletitled, Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
Open the PDF for Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Free
Russell Scott, MB CHB, PHD, FRACP, Richard O'Brien, MB, PHD, FRACP, Greg Fulcher, MB, MD, FRACP, Chris Pardy, Michael d'Emden, MB BS, PHD, FRACP, Dana Tse, PHD, Marja-Riitta Taskinen, MD, Christian Ehnholm, MD, PHD, Anthony Keech, MB BS, FRACP, MSC(EPID), on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(3):493–498
https://doi.org/10.2337/dc08-1543
Published: 01 March 2009
View articletitled, Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Open the PDF for Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study in another window
Includes: Supplementary data
Journal Articles

Cigarette Smoking Affects Glycemic Control in Diabetes

Free
Jenny E. Gunton, MBBS, FRACP, Linda Davies, BAPPSC, Errol Wilmshurst, MBBS, MRACP, MD, FRACP, Greg Fulcher, MBBS, MD, FRACP, Aidan McElduff, MBBS, PHD, FRACP
Journal: Diabetes Care
Diabetes Care 2002;25(4):796–797
https://doi.org/10.2337/diacare.25.4.796-a
Published: 01 April 2002
View articletitled, Cigarette Smoking Affects Glycemic Control in Diabetes
Open the PDF for Cigarette Smoking Affects Glycemic Control in Diabetes in another window